Patients and Methods: This was part of a prospective, uncontrolled, consecutive case series
study. Patients with primary open-angle glaucoma or pseudo-exfoliative glaucoma were
included. All the patients underwent surgical XEN implant procedure with mitomycin-C
subconjunctival injection 20 minutes before surgery. Success criteria were an off-medication
IOP of 6 to 16 mm Hg 12 months after surgery; no additional glaucoma surgery; no visual …